Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy

Movement Disorders

Volumn 26, Issue 2, 2011, Pages 256-263

  Schofield, Emma C ^a   Hodges, John R ^a   Macdonald, Virginia ^a   Cordato, Nicholas J ^b   Kril, Jillian J ^c   Halliday, Glenda M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Calvary Health Care ^*  (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Atrophy; Parkinsonism; Progressive supranuclear palsy; Richardson's syndrome

Indexed keywords

ADULT; AGED; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; ASTROCYTE; BRAIN CORTEX ATROPHY; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; GLOBUS PALLIDUS; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; INFERIOR FRONTAL GYRUS; MALE; MOTOR CORTEX; OCCIPITAL CORTEX; OLIGODENDROGLIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROGRESSIVE SUPRANUCLEAR PALSY PARKINSONISM; PROGRESSIVE SUPRANUCLEAR PALSY RICHARDSON SYNDROME; PUTAMEN; SUPRAMARGINAL GYRUS; TAUOPATHY; THALAMUS;

ASTROCYTES; ATROPHY; CELL COUNT; CEREBRAL CORTEX; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEURONS; OLIGODENDROGLIA; PARKINSONIAN DISORDERS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 79952655245     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23295     Document Type: Article

References (41)

1. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128: 1247-1258.
2. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009; 8: 270-279.
3. Arai T, Ikeda K, Akiyama H, et al. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol 2001; 101: 167-173.
4. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996; 55: 97-105.
5. Jellinger KA. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegener Dis 2008; 5: 339-346.
6. Williams DR, Holton JL, Strand C, et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 2007; 130: 1566-1576.
7. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain 2006; 129: 1040-1049.
8. Quattrone A, Nicoletti G, Messina D, et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008; 246: 214-221.
9. Slowinski J, Imamura A, Uitti RJ, et al. MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 2008; 255: 37-44.
10. Warmuth-Metz M, Naumann M, Csoti I, Solymosi L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 2001; 58: 1076-1079.
11. Song YJC, Huang Y, Halliday GM. Clinical correlates of similar pathologies in parkinsonian syndromes. Mov Disord 2009;under resubmission
12. Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004; 75: 246-249.
13. Cordato NJ, Duggins AJ, Halliday GM, Morris JG, Pantelis C. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy. Brain 2005; 128: 1259-1266.
14. Gröschel K, Hauser TK, Luft A, et al. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage 2004; 21: 714-724.
15. Cordato NJ, Halliday GM, Harding AJ, Hely MA, Morris JG. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease. Ann Neurol 2000; 47: 718-728.
16. Schofield EC, Caine D, Kril JJ, Cordato NJ, Halliday GM. Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration. Mov Disord 2005; 20: 34-39.
17. Cordato NJ, Halliday GM, McCann H, et al. Corticobasal syndrome with tau pathology. Mov Disord 2001; 16: 656-667.
18. Halliday GM, Double KL, Macdonald V, Kril JJ. Identifying severely atrophic cortical subregions in Alzheimer's disease. Neurobiol Aging 2003; 24: 797-806.
19. Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, McCusker E. Regional specificity of brain atrophy in Huntington's disease. Exp Neurol 1998; 154: 663-672.
20. Double KL, Halliday GM, Kril JJ, et al. Topography of brain atrophy during normal aging and Alzheimer's disease. Neurobiol Aging 1996; 17: 513-521.
21. Harasty JA, Halliday GM, Kril JJ, Code C. Specific temporoparietal gyral atrophy reflects the pattern of language dissolution in Alzheimer's disease. Brain 1999; 122: 675-686.
22. Kril JJ, Halliday GM. Clinicopathological staging of frontotemporal dementia severity: correlation with regional atrophy. Dement Geriatr Cogn Disord 2004; 17: 311-315.
23. Kril JJ, Halliday GM, Svoboda MD, Cartwright H. The cerebral cortex is damaged in chronic alcoholics. Neuroscience 1997; 79: 983-998.
24. Bergeron C, Pollanen MS, Weyer L, Lang AE. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration. J Neuropathol Exp Neurol 1997; 56: 726-734.
25. Hardman CD, Halliday GM. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease. Exp Neurol 1999; 158: 135-142.
26. Henderson JM, Carpenter K, Cartwright H, Halliday GM. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000; 123: 1410-1421.
27. Halliday GM, Macdonald V, Henderson JM. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease. Brain 2005; 128: 2272-2280.
28. Halliday GM, Hardman CD, Cordato NJ, Hely MA, Morris JG. A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy. Brain 2000; 123: 724-732.
29. Juncos JL, Hirsch EC, Malessa S, Duyckaerts C, Hersh LB, Agid Y. Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology 1991; 41: 25-30.
30. Revesz T, Sangha H, Daniel SE. The nucleus raphe interpositus in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Brain 1996; 119: 1137-1143.
31. Okuda B, Tachibana H, Kawabata K, Takeda M, Sugita M. Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. Alzheimer Dis Assoc Disord 2000; 14: 46-52.
32. Varrone A, Pagani M, Salvatore E, et al. Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease. Eur J Nucl Med Mol Imaging 2007; 34: 1071-1081.
33. Borroni B, Alberici A, Agosti C, Cosseddu M, Padovani A. Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy. Int Psychogeriatr 2009; 21: 463-468.
34. Bak TH, Hodges JR. The neuropsychology of progressive supranuclear palsy. Neurocase 1998; 4: 89-94.
35. Bak TH, Rogers TT, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2005; 76: 420-422.
36. Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase 2005; 11: 268-273.
37. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37: 121-130.
38. Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006; 63: 81-86.
39. Mesulam MM. Spatial attention and neglect: parietal, frontal and cingulate contributions to the mental representation and attentional targeting of salient extrapersonal events. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1325-1346.
40. Grafman J, Litvan I, Gomez C, Chase TN. Frontal lobe function in progressive supranuclear palsy. Arch Neurol 1990; 47: 553-558.
41. Paviour DC, Schott JM, Stevens JM, et al. Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004; 75: 1772-1775.